Tag: Commercial Agreement
MIMETAS And Hubrecht Organoid Technologies Partner To Market Organoids-On-A-Chip
MIMETAS and Hubrecht Organoid Technologies (HUB) have
entered into a strategic collaboration to market organoid models on a Chip. The
agreement includes a license to MIMETAS to market HUB Organoids in an assay
ready format, as well as a collaborative effort to...
Grünenthal And Mesoblast Partner To Develop Allogeneic Cell Therapy For Chronic Low Back Pain
Grünenthal, a global leader in pain management, and
Mesoblast Limited, a world leader in allogeneic cellular medicines for
inflammatory diseases, have entered into a strategic partnership to develop and
commercialise MPC-06-ID, a Phase III allogeneic cell therapy candidate for the
treatment of chronic...
Evotec And Indivumed Form Agreement Granting Access To CRC Cohort Of IndivuType Database
Evotec SE and Indivumed GmbH have announced that they have
entered into a research collaboration to discover and develop first-in-class
therapeutics for the treatment of colorectal cancer ("CRC"). The
collaboration, which runs for an initial term of two years, will combine
Evotec's proprietary...
ThermoGenesis Expands Commercial Access To Its Bioprocessing Equipment
ThermoGenesis Corp., a wholly owned subsidiary of Cesca
Therapeutics, and a market leader in automated cellular processing and
autologous cell therapies for regenerative medicine, has announced that its
AXP® II System for cord blood processing and PXP® System for point-of-care
harvesting of highly...
Trans-Hit Bio And Maricopa Integrated Health System Biobank Work Together To Support Industry R&D
Trans-Hit Bio (THB) is the worldwide biospecimen access CRO, founded in 2009, headquartered in Montréal, Québec, with a most extensive collection capability for biospecimens and clinical samples through an unrivalled worldwide partnered-network of state-of-the-art biorepositories. The company, led by...
